Since the takeover by Roche budgets cut and continue to be cut. upper management is stale and outdated as most have been with the company to long. EC promotes speaking out but latest internal employee survey shows @53% of employees are afraid to speak out because of retaliation. Still offers great benefits but slow to adopt to change as new start ups are more flexible. HR doesn't follow own policies. Has managers jump through hoops to discipline poor performers but upper management will bypass system and terminate using "As will" whenever someone speaks out for change". Genentech just announced job freeze in commercial and US Medical Affairs departments as others are not far behind. This is a direct result of Roche not being an innovative company deriving 46% of their total revenue from Genentech.
![[iito] Life Science](http://pbs.twimg.com/profile_images/555518370523525120/54L7-_yi_normal.jpeg)
